10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615 | -26.1% | 14,900 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $832 | +4.3% | 14,900 | +4.2% | 0.00% | -20.0% |
| Q1 2023 | $798 | +53.2% | 14,300 | 0.0% | 0.01% | +66.7% |
| Q4 2022 | $521 | -99.9% | 14,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $407,000 | -37.1% | 14,300 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $647,000 | -35.0% | 14,300 | +9.3% | 0.00% | -33.3% |
| Q1 2022 | $995,000 | -45.2% | 13,082 | +7.4% | 0.01% | -33.3% |
| Q4 2021 | $1,815,000 | +66.5% | 12,182 | +62.8% | 0.01% | +50.0% |
| Q3 2021 | $1,090,000 | -25.6% | 7,484 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $1,466,000 | -36.2% | 7,484 | -41.1% | 0.01% | -38.5% |
| Q1 2021 | $2,299,000 | +18.5% | 12,700 | -7.3% | 0.01% | +8.3% |
| Q4 2020 | $1,940,000 | – | 13,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |